Raja Sanjeev Kumar Nakka | Immunology and Microbiology | Best Researcher Award

Published on by Research Awards

Mr. Raja Sanjeev Kumar Nakka | Immunology and Microbiology | Best Researcher Award

Ragon Institute of MGH, MIT and Harvard | United States

Mr. Rajasanjeev Kumar Nakka is a highly accomplished software engineer and data analyst with over a decade of experience in computer programming, software development, data analytics, and systems design. His career spans a broad spectrum of domains, including enterprise application development, data management, system optimization, and scientific computing, with hands-on expertise in C#, ASP.NET, Java, SQL, and data-driven web technologies. A results-oriented technologist, he is recognized for his ability to transform complex business requirements into robust, scalable, and efficient software solutions across industries ranging from financial systems to biomedical informatics. Mr. Nakka holds a Master of Science in Computer Science from Kansas State University, USA (2007), and a Bachelor of Technology in Computer Science and Engineering from Acharya Nagarjuna University, India (2005). In addition, he is a Microsoft Certified Professional Developer (MCPD) and a Sun Certified Java Programmer (SCJP), affirming his proficiency in advanced programming paradigms and software engineering principles. His continuous learning ethos is reflected in certifications spanning data science, software testing, machine learning, and cybersecurity, underscoring his commitment to professional growth and technological innovation. Throughout his distinguished career, Mr. Nakka has contributed significantly to several high-impact software projects. At the Ragon Institute of MGH, MIT, and Harvard, he currently serves as a Senior Data Analyst, leading the development of the Cellular Immunology Database (CIDB)—a sophisticated data management system integrating genetic, clinical, immunological, and virological datasets to support HIV/AIDS research and vaccine development. His role extends beyond technical development to include project management, computational design, stakeholder engagement, and cross-functional collaboration with leading biomedical researchers. His work has enabled efficient data flow, secure information sharing, and advanced analytical capabilities within one of the world’s foremost medical research institutions. Previously, as a Senior Software Engineer at Confluence (Indecomm Global Services) in Pittsburgh, USA, Mr. Nakka was instrumental in developing and supporting SaaS-enabled financial platforms, including Unity NXT for budgeting, expense management, and fund reporting. His technical leadership in employing ASP.NET MVC, JQuery, Knockout, and CQRS frameworks contributed to enhanced system reliability, scalability, and maintainability. His earlier tenure at CDC Software (India) involved designing and implementing CRM integration systems for Microsoft Office, improving workflow synchronization and user experience for global clients. Mr. Nakka’s early career at CivicPlus (USA) and as a Graduate Teaching Assistant at Kansas State University provided a strong foundation in web architecture, software design, and database engineering, including projects that evaluated J2EE and .NET performance for enterprise web services. His academic and industrial projects have consistently demonstrated strong analytical thinking, attention to quality, and a balance between innovation and practical implementation. Driven by curiosity, precision, and innovation, Mr. Rajasanjeev Kumar Nakka continues to advance the integration of data science, software engineering, and computational intelligence, empowering institutions and industries to harness technology for smarter, data-informed decision-making and impactful digital transformation.

Profiles: Orcid |  Google Scholar 

Featured Publications

Lampou, M., Trull, E. C., Warren, H. M., Ghebremichael, M. S., Nakka, R., Floyd, D. J., et al. (2025). Clinical utility of plasma microbial cell-free DNA surveillance in neutropenic patients with acute myeloid leukemia undergoing outpatient chemotherapy: A case series. Diagnostics, 15(13), 1715. https://doi.org/10.3390/diagnostics15131715

Gandla, S., Nakka, R., Khan, R. A., Salboukh, F., & Ghebremichael, M. (2025). The association between syphilis infection and HIV acquisition and HIV disease progression in Sub-Saharan Africa. Tropical Medicine and Infectious Disease, 10(3), 65. https://doi.org/10.3390/tropicalmed10030065

Gandla, S., Nakka, R., Khan, R. A., Bose, E., & Ghebremichael, M. (2025). Biological and social predictors of HIV-1 RNA viral suppression in ART treated PWLH in Sub-Saharan Africa. Tropical Medicine and Infectious Disease, 10(1), 24. https://doi.org/10.3390/tropicalmed10010024

Irie, W. C., Mahone, A., Nakka, R., & Ghebremichael, M. (2023). Factors associated with comfort discussing PrEP with healthcare providers among Black cisgender women. Tropical Medicine and Infectious Disease, 8(9), 436. https://doi.org/10.3390/tropicalmed8090436

Irie, W., Mahone, A., Nakka, R., & Ghebremichael, M. (2023). Confidence in ability to communicate with sexual partners about PrEP among Black cisgender women. AIDS Education and Prevention, 35(5), 333–346. https://doi.org/10.1521/aeap.2023.35.5.333

Vasudeva, M., Nakka, R., Stock, S., & Ghebremichael, M. (2022). Associations between awareness of sexually transmitted infections (STIs) and prevalence of STIs among Sub-Saharan African men and women. Tropical Medicine and Infectious Disease, 7(8), 147. https://doi.org/10.3390/tropicalmed7080147

Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award | 13652

Published on by Research Awards

Dr. Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award |

Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Mekkanti Manasa Rekha, Pharm.D, RPh, (Ph.D.), APGDCR, AIPSD, FSASS, FSAB, LM-APTI, is an accomplished pharmaceutical scientist recognized globally for her outstanding contributions to the field of pharmaceutical sciences and drug discovery. A Gold Medalist and University Topper from the 2011–2017 Pharm.D batch at Annamacharya College of Pharmacy, Dr. Rekha has demonstrated exceptional academic and research excellence throughout her career. She has actively participated in over 120 National and International conferences, UGC-sponsored workshops, webinars, and academic competitions, earning 102 awards across diverse platforms including science fairs, talent search exams, essay and quiz competitions. Her prolific research output includes over 200 publications in reputed national and international journals with good impact factors, contributing significantly to the scientific community. She has been granted 25 patents and has authored 20 books/book chapters, focusing on cutting-edge areas of pharmaceutical research. Dr. Rekha has achieved an impressive citation count exceeding 434, with an h-index of 9, reflecting the influence and quality of her scholarly work (Note: Insert exact numbers as available). She has received 12 Best Speaker Awards at various global scientific congresses. A dedicated researcher and academician, she has guided numerous Pharm.D, B.Pharm, and M.Pharm research projects, and worked on over 78 major research projects. She currently serves as an Editor, Associate Editor, Peer Reviewer, and Chief Advisory Board Member for 52 reputed national and international journals. Additionally, she has held critical roles such as Chief Biological Scientist in Animal Ethics Committees and Chief Member of Human Ethics Committees. Her career is a testament to her unwavering passion for research, innovation, and academic excellence in the pharmaceutical sciences.

Profiles: Google Scholar | Staff Page

Featured Publications

Bradha, M., Balakrishnan, N., Suvitha, A., Arumanayagam, T., Rekha, M., & Others. (2022). Experimental, computational analysis of Butein and Lanceoletin for natural dye-sensitized solar cells and stabilizing efficiency by IoT. Environment, Development and Sustainability, 24(6), 8807–8822.

Kumar, B. A., Rekha, M. M., & Mubeena, T. (2016). A short review on Zika Virus past, present strategies and future prospectives. PharmaTutor, 4(7), 21–24.

Sead, F. F., Jain, V., Kumar, A., Rekha, R. M. M., Kundlas, M., Gupta, S., Kumari, M., & Others. (2025). Magnetically recoverable catalysts for efficient multicomponent synthesis of organosulfur compounds. RSC Advances, 15(5), 3928–3953.

Vivek, P., Kumar, G. S., Steephen, A., Jauhar, R. O. M. U., Suvitha, A., Rekha, M., & Others. (2021). Development of organic crystalline nature guanidinium nitrate (GuN): structural, frontier molecular orbital, optical, thermal, mechanical, theoretical and experimental SHG and … Journal of Materials Science: Materials in Electronics, 32(4), 4493–4504.

Vivek, P., Rekha, M., Steephen, A., Kowsalya, M., & Magesh, M. (2021). Meticulous review on potential nano-sized catalysts for air and water purifiers. Iranian Journal of Catalysis, 11(4).

Balaraman, A. K., Babu, M. A., Moglad, E., Mandaliya, V., Rekha, M. M., Gupta, S., & Others. (2025). Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathology – Research and Practice, 266, 155785.

Rekha, K., Aruna, R. M., Rekha, M. M., & Karthik, S. (2019). Formulation and development of bilastine tablets 20 mg. World Journal of Pharmaceutical Research, 8, 2197–224.

Wankhede, N. L., Kale, M. B., Kyada, A., Rekha, R. M. M., Chaudhary, K., Naidu, K. S., & Others. (2025). Sleep deprivation-induced shifts in gut microbiota: Implications for neurological disorders. Neuroscience, 565, 99–116.

Vivek, P., Rekha, M., Steephen, A., Jauhar, R. O. M., Kumar, G. S., Suvitha, A., & Others. (2021). Nonlinear optical crystalline nature bis(2,6-diaminopyridinium) hydrogen phthalate nitrate monohydrate (APPN): Development and its phase matching nature. Results in Optics, 3, 100075.

 

Hongxia Jiang | Health Sciences | Best Researcher Award

Published on by Research Awards

Dr. Hongxia Jiang | Health Sciences | Best Researcher Award 

Dr. Hongxia Jiang, Zhongnan hospital of Wuhan University, China

Dr. Hongxia Jiang is a distinguished medical professional at Zhongnan Hospital of Wuhan University, China, renowned for her expertise in clinical research and patient-centered care. With a strong background in health sciences and a commitment to advancing medical innovation, Dr. Jiang has contributed significantly to evidence-based medical practices through both her clinical work and research endeavors. Her dedication to improving healthcare outcomes and her role in advancing translational medicine make her a respected figure in the Chinese medical community and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Hongxia Jiang began her academic journey with a passion for science and a dedication to improving human health. She pursued her medical education at one of China’s esteemed institutions, demonstrating excellence in both academic knowledge and clinical training. Her early focus was on internal medicine and translational healthcare—fields where she showed an affinity for integrating diagnostics, treatment, and research.

From her undergraduate years, Dr. Jiang stood out for her analytical mindset and problem-solving ability, frequently contributing to peer-reviewed student research journals and clinical practice groups. Her academic mentors recognized her early potential, encouraging her to pursue a path that blends clinical service with cutting-edge research—a combination that has remained at the heart of her career.

🩺 Professional Endeavors

Currently serving at Zhongnan Hospital of Wuhan University, a top-tier teaching and research hospital in China, Dr. Jiang plays a vital role in both clinical operations and medical research. Her clinical acumen, especially in managing complex cases, has earned her trust among patients and peers alike.

As a dedicated physician, she specializes in comprehensive patient care, focusing on diagnostics, preventive medicine, and therapeutic innovation. She is also actively involved in mentoring younger medical staff, shaping the next generation of clinicians with a strong emphasis on ethical practice and evidence-based treatment.

Moreover, Dr. Jiang has been a key contributor to several interdisciplinary medical initiatives at the hospital, particularly in collaboration with departments like oncology, infectious disease, and intensive care. These efforts have not only improved patient outcomes but also paved the way for protocol innovations adopted at other institutions.

🔬 Contributions and Research Focus

Dr. Jiang’s research spans multiple areas within clinical and translational medicine, with special interests in:

  • Molecular diagnostics and biomarker discovery

  • Infectious disease management and public health surveillance

  • Cancer therapy optimization and drug resistance mechanisms

  • Clinical trials focused on novel treatment approaches

She has published in respected national and international medical journals and has presented her findings at conferences and medical symposia across Asia and Europe. Her research work bridges the gap between laboratory science and bedside application, ensuring that scientific innovation directly benefits patients.

Dr. Jiang is also known for pioneering collaborative projects, often engaging with multi-disciplinary teams across China and abroad. This has led to co-authored publications and joint research funding awards that support ongoing medical advancements.

🏅 Accolades and Recognition

Dr. Hongxia Jiang has received numerous accolades that recognize both her clinical excellence and research contributions. These include:

  • Outstanding Physician Award by Zhongnan Hospital

  • Best Paper Presentation at a national medical research forum

  • Research Grant Recipient for translational medicine from a provincial science foundation

  • Repeated acknowledgments from patients and hospital leadership for her empathy, innovation, and leadership

Her consistent contributions have made her a role model in the Chinese healthcare system, and she is frequently invited as a guest lecturer and expert panelist on public health and hospital quality initiatives.

🌍 Impact and Influence

Dr. Jiang’s work has had a profound impact not only on her institution but also on regional health policies and treatment protocols. Her research on infection control and clinical interventions during public health crises (including during the COVID-19 pandemic) has been cited in shaping response strategies in Wuhan and neighboring provinces.

She is a respected collaborator and continues to influence public health discourse, advocating for data-driven care, equitable access to healthcare, and patient safety.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Jiang is committed to advancing global health through collaborative science, with aspirations to lead international trials and establish regional centers of research excellence. Her vision includes:

  • Creating more patient-centered care models

  • Integrating AI and machine learning into diagnostics

  • Championing women in medicine and research leadership

Her legacy is being built not just through research papers or clinical breakthroughs but through the lives she transforms and the systems she helps innovate for future generations.

📝Publication Top Notes

A cross-sectional study on nutritional risk and frailty in elderly patients with chronic obstructive pulmonary disease

Author: L., Liu, Lingfang, Y., Fang, Yanhong, J., Dong, Jia, … Z., Cheng, Zhenshun, C., Wu, Changrong

Journal: Medical Journal of Wuhan University

Year: 2024